The research found that expression levels of the Augmin family genes HAUS1, HAUS3, HAUS4, HAUS5, HAUS6, HAUS7, and HAUS8 was all related with survival rates of glioma patients. This evidence concerns the gene HAUS5 and central nervous system cancer.